Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Receivables - NetReceivables - Other
Ratios

China SXT Pharmaceuticals (SXTC) Shares Outstanding (2020 - 2022)

China SXT Pharmaceuticals has reported Shares Outstanding over the past 3 years, most recently at $10157.0 for Q1 2022.

  • For Q1 2022, Shares Outstanding fell 67.29% year-over-year to $10157.0; the TTM value through Mar 2022 reached $10157.0, down 67.29%, while the annual FY2022 figure was $2.0 million, 6442.33% up from the prior year.
  • Shares Outstanding for Q1 2022 was $10157.0 at China SXT Pharmaceuticals, down from $31050.0 in the prior quarter.
  • Over five years, Shares Outstanding peaked at $433346.0 in Q1 2020 and troughed at $10157.0 in Q1 2022.
  • A 3-year average of $158184.3 and a median of $31050.0 in 2021 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: plummeted 92.83% in 2021 and later crashed 67.29% in 2022.
  • Year by year, Shares Outstanding stood at $433346.0 in 2020, then plummeted by 92.83% to $31050.0 in 2021, then crashed by 67.29% to $10157.0 in 2022.
  • Business Quant data shows Shares Outstanding for SXTC at $10157.0 in Q1 2022, $31050.0 in Q1 2021, and $433346.0 in Q1 2020.